bluebird bio Inc (BLUE)

52.42 -1.31  -2.44% NASDAQ Oct 28, 17:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/11/2021 Misc Bluebird Bio Inc First Quarter Earnings Conference Call for 2021
10/30/2020 Earnings Bluebird Bio Inc Third Quarter Earnings Results for 2020
08/05/2020 Earnings Bluebird Bio Inc Second Quarter Earnings Results for 2020
06/18/2020 08:30 EDT Misc Bluebird Bio Inc Annual General Meeting for 2019
05/11/2020 08:00 EDT Misc Bluebird Bio Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Bluebird Bio Inc First Quarter Earnings Result for 2020
02/18/2020 Earnings Bluebird Bio Inc Fourth Quarter Earnings Results for 2019
02/18/2020 Misc Bluebird Bio Inc Annual Report for 2019
10/31/2019 Earnings Bluebird Bio Inc Third Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.bluebirdbio.com
  • Investor Relations URL: http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Oct. 30, 2020
  • Last Earnings Release: Aug. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Top Fund Holders

Symbol Name Weighting
NEC214 Next Edge Bio-Tech Plus F 3.94%
FBT First Trust NYSE Arca Biotech ETF 3.25%
GNOM Global X Genomics & Biotechnology ETF 2.92%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 2.75%
NIFE Direxion Fallen Knives ETF 2.71%
CNCR Loncar Cancer Immunotherapy ETF 2.55%
RIFKX Victory RS Science and Technology R 1.52%
F000013KMW ST Healthcare Innovations 7 F RE 1.11%
USTCX USAA Science & Technology Class A 1.05%
KRXCX Kinetics Medical Adv C 0.63%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.